Growth Portfolio Watchlist
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
First up is Sigma Pharmaceuticals (SIG - $2.64). Our last review in issue 84 (Hold for Upside - $2.68) commented that with Faulding being acquired, there may be more takover activity. Next, a couple from our sister publication, the GTS Report. ION (ION - $1.23), a manufacturer of engine components and iron carbide technology licensee has increased 24% since our first review in mid-June (Buy - $0.99). It's still a buy, as is mailing house and billing system supplier, HPAL (HPX - $2.35), as we said in GTS 22 (Buy - $2.15).
We've never reviewed Sabre (SBE - $1.62) a distributor of hair care products, but we do like the look of it. Finally to an old favourite, Westfield Holdings (WSF - $14.50). It's up 7% since issue 82 (Long Term Buy - $13.44) and is still a long term buy. But, we're waiting to see how its international operations are going before including it in the the portfolio.
Call 1300 880 160
Start a chat
Schedule a call
